Older Americans are deeply concerned about prescription drug prices.

This isn't surprising when you consider that the U.S. has the highest total drug expenditure and most pharmaceutical spending per capita among developed countries, which experts put down to steep drug prices, according to a new report from MedicareGuide, a Miami-based health insurance marketing program company that runs the HealthCare.com health insurance shopping website.

Federal help may be on the way, but getting there will be a slog. The report notes that the Biden administration recently announced its support for Medicare to directly negotiate drug prices with pharmaceutical manufacturers and pass those lower rates along to consumers. At the same time, it delayed enforcement of a new rule that requires insurers to publish prescriptions prices from Jan. 1 until July 2022.